Search by Drug Name or NDC
NDC 45802-0619-06 SUMATRIPTAN 5 mg/1 Details
SUMATRIPTAN 5 mg/1
SUMATRIPTAN is a NASAL SPRAY in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is SUMATRIPTAN.
MedlinePlus Drug Summary
Sumatriptan nasal products are used to treat the symptoms of migraine headaches (severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound and light). Sumatriptan is in a class of medications called selective serotonin receptor agonists. It works by narrowing blood vessels around the brain, stopping pain signals from being sent to the brain, and blocking the release of natural substances that cause pain, nausea, and other symptoms of migraine. Sumatriptan does not prevent migraine attacks or reduce the number of headaches you have.
Related Packages: 45802-0619-06Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Sumatriptan Nasal
Product Information
| NDC | 45802-0619 |
|---|---|
| Product ID | 45802-619_ad04acff-e168-419b-a127-ee66e9bb9b8d |
| Associated GPIs | 67406070002010 |
| GCN Sequence Number | 030735 |
| GCN Sequence Number Description | sumatriptan SPRAY 5 MG NASAL |
| HIC3 | H3F |
| HIC3 Description | ANTIMIGRAINE PREPARATIONS |
| GCN | 50740 |
| HICL Sequence Number | 012779 |
| HICL Sequence Number Description | SUMATRIPTAN |
| Brand/Generic | Generic |
| Proprietary Name | SUMATRIPTAN |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | sumatriptan |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SPRAY |
| Route | NASAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/1 |
| Substance Name | SUMATRIPTAN |
| Labeler Name | Padagis Israel Pharmaceuticals Ltd |
| Pharmaceutical Class | Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA213465 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 45802-0619-06 (45802061906)
| NDC Package Code | 45802-619-06 |
|---|---|
| Billing NDC | 45802061906 |
| Package | 6 CONTAINER in 1 CARTON (45802-619-06) / 1 SPRAY in 1 CONTAINER (45802-619-00) |
| Marketing Start Date | 2020-10-04 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 36.5567 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | SUMATRIPTAN 5 MG NASAL SPRAY |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis